The dual GLP-1/GIP receptor agonist is also being investigated in an additional Phase II study (CT388-104) to evaluate its efficacy, safety and tolerability in participants who are living with obesity or are overweight and have type 2 diabetes (T2D)
A generic medication contains the same active ingredient, at the same dose, delivered in the same way as the brand-name version
A $30 bottle sounds cheap until you learn you need six gummies a day
The Phase 2 trial reference point The Phase 2 retatrutide trial (Jastreboff et al., New England Journal of Medicine 2023) enrolled 338 adults across placebo and retatrutide arms at 1, 4, 8, and 12 mg weekly
doi: 10.1017/S0007114520002172 43 dos SantosEPGadelhaABSafonsMPNobregaOTOliveiraRJLimaRM
The total investment in your weight management program depends on your personalized treatment plan, including medication type, dosage, and duration